Search results :

Ropivacaine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N01BB09

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Hypotension 15.2% - 58.4% x x x x x x x x
Nausea 3.9% - 40.4% x x x x x x x x
Bradycardia 2.2% - 19.5% x x x x x x x x
Bradycardia foetal 0.3% - 28.6% x x x x x x
Oliguria 10.2% x x x x x x x x
Vomiting 2.3% - 20% x x x x x x x
Unexpected therapeutic effect 7.9% x
Back pain 2.9% - 16.4% x x x x x x x x
Jaundice neonatal 0.2% - 8.2% x x x x x x
Anaemia 0.2% - 13.8% x x x x x x
Hypoproteinaemia 5.4% x
Headache 2.3% - 8.1% x x x x x x x x
Pain 0.9% - 16.8% x x x x x x
Abdominal pain 1.1% - 4.3% x
Pruritus 0.3% - 9% x x x x x x x
Body temperature increased 0.8% - 20.7% x x x x x x x x
Creatine phosphokinase increased 3.4% x
Hypoxia 0.4% - 6.3% x
Leukocytosis 3.2% x
Postoperative complications NOS 0.6% - 15% x x x x x x
Hypokalaemia 0.3% - 5.8% x x x x x x
Hypocalcaemia 3% x
Paraesthesia 1.4% - 25.4% x x x x x x x x
Urine abnormality 2.9% x x
Haematuria 0.9% - 4.6% x
Orthostatic hypotension 2.5% x x x x x x
Tachypnoea 1.3% - 3.5% x
Fever neonatal 2% - 2.6% x x x x x x
Apgar score low 1.7% - 2.8% x x x x x
Neonatal tachypnoea 2.2% - 2.6% x x x x x
Body temperature decreased 0.1% - 4.6% x x x x x x x x
Dyskinesia 2.3% x x x x x x
Urinary retention 0.9% - 4.83% x x x x x x
Chills 1.2% - 6.2% x x x x x x x x
Dizziness 1.1% - 10% x x x x x x x x
Rigors 1.2% - 6.2% x x x x x x x x
Phosphatase alkaline increased 2.1% x
Tachycardia foetal 2% - 3% x x x x x x
Thrombocytopenia 2% x
Insomnia 2% x x x x x x x x
Pleural effusion 1.9% x
Thrombocytosis 1.9% x
Faecal incontinence 1.8% x x x x x x
Pyuria 1.8% x
Aspartate aminotransferase increased 1.8% x
Abnormal labour 1.7% x
Foetal distress syndrome 1.7% - 4.3% x x x x x x
Hyperglycaemia 1.7% x
Hypoaesthesia 0.6% - 3.3% x x x x x x x x
Urinary tract infection 0.1% - 3.5% x x x x x x
Vomiting neonatal 1.7% x x x x x x x
Atelectasis 1.6% x x
Dyspepsia 0.1% - 3.1% x
Albuminuria 1.5% x
Rales 1.5% x
Oedema peripheral 0.6% - 2.4% x
Neonatal infection 1.4% - 1.6% x x x x
Respiratory disorder neonatal 1.3% - 1.7% x x
Blood urea decreased 1.4% x
Enlargement abdomen 0.1% - 2.5% x
Cough 1.3% x x x x x x x
Jaundice 1.3% x x x x x x
Respiratory insufficiency 1.3% x
Tachycardia 0.5% - 4.4% x x x x x x x x
Hypoglycaemia neonatal 1.3% - 2.8% x x x x
Postpartum haemorrhage 1.2% x
Injection site inflammation 1.2% x
Prothrombin level decreased 1.2% x
Injection site reaction 0.2% - 2.1% x
Infection 0.5% - 2% x
Breast disorder 0.8% - 1.3% x x x x
Breast feeding 0.8% - 1.3% x x x x
Hepatic function abnormal 1% x
Application site reaction 1% x
Rhinitis 0.9% - 1.1% x x x x
Somnolence 0.6% - 1.3% x x x x x x
Anxiety 0.2% - 4% x x x x x x x x
Tremor 0.2% - 1.2% x x x x x x
Bronchospasm 0.1% - 1.5% x x x x x x x
Agitation 0.2% - 1.3% x x x x x x
Alanine aminotransferase increased 0.2% - 1.3% x
Paresis 0.1% - 1.3% x x x x x x
Dyspnoea 0.2% - 2.6% x x x x x x x x
Rash 0.5% - 1.8% x x x x x x
Hypertension 0.5% - 8.3% x x x x x x x x
Urinary incontinence 0.5% - 1.3% x x x x x x
Chest pain 0.5% - 2.9% x x x x x x x x
Myalgia 0.1% - 1% x x x x x x
Arrhythmia 0.2% - 1% x x x x x x x x
Arthralgia 0.5% - 1.6% x
Dysuria 0.3% - 1.4% x
Purpura 0.4% - 1.1% x
Micturition disorder 0.2% - 1% x x x x x x
Sweating increased 0.4% - 1.3% x x x x x x x
Diarrhoea 0.1% - 4.9% x
Confusional state 0.2% - 1.8% x x x x x x
Constipation 0.1% - 4.3% x
Acidosis x x x x x x x
Amnesia x x x x x
Anaphylactic shock x x
Angioedema x x x x x x x x
Apnoea x x x x x x x
Arachnoiditis x x x
Asthenia x x x x x x
Atrial fibrillation x x x x x
Mental disorder x x x x x
Cardiac output decreased x x x x x x
Coma x x x x x
Depression x
Drowsiness x x x x x x
Dysarthria x x
Grand mal convulsion x
Hallucination x x x x x
Cardiac arrest x x x x x x x x
Block heart x x x x x x
Heart malformation x
Cardiac disorder x x
Horner's syndrome x x x x x
Hypercapnia x x
Hyperkalaemia x x
Hypersensitivity x x x x x x x
Hypoglycaemia x x x
Laryngeal oedema x x x x x x
Laryngospasm x
Meningism x x x x x x
Meningitis x x x x x x x
Metabolic disorder x x x x x
Miosis x
Cramp muscle x x x x x
Hypotonia x x x x x x
Muscle rigidity x x
Myocardial infarction x x x x x
Nervousness x x x x x
Nightmare x x x x x
Phlebitis x x x x x
Pulmonary embolism x x x x x
Respiratory paralysis x x x x x x
Convulsion x x x x x x x x
Shock x x x
Skin disorder x x x x x
Sneezing x x x x x x
Muscle spasms x
Syncope x x x x x x x x
Tinnitus x x x x x x
Loss of consciousness x x x x x x x x
Erythema x x x x x x
Urinary tract disorder x x x x x
Urticaria x x x x x x x x
Uterine atony x x x x x
Ventricular fibrillation x x x x x x
Ventricular tachycardia x x x x x x
Vertigo x x x x x
Ventricular arrhythmia x x x x x x
Vasospasm x
Stupor x x x x x
Mood swings x x x x x
Hypokinesia x x x x x
Deep vein thrombosis x x x x x
Cranial nerve paralysis x x x x x x
CNS depression NOS x x
Hypomagnesaemia x x x x x
Injection site pain x x x x x
Prolonged labour x x x x x
Respiratory arrest x x x x x x x x
Anterior spinal artery syndrome x x x
Malaise x x x x x
Muscle twitching x x
Rectal tenesmus x x x x x
Excitement x x x x x x
Neurologic reaction x x x x x
Respiratory depression x
Extradural abscess x x
Extrasystoles x x x x x
Anaphylactoid reaction x x
Vision blurred x x x x x x x
Cauda equina syndrome x x x
Foetal acidosis x
Electrocardiogram ST segment x x x x x
Laboratory test abnormal x
Neuropathy x x x x x x x x
Sepsis neonatal x
Total spinal block x x x x x x x
Paralysis x x x x x x
Excitation cerebral x
Needle injury x x
Spinal haematoma x x
Ileus x
CNS toxicity x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ROPIVACAINE

Side effects:105
Source:FDA Structured Product Label

ROPIVACAINE

Side effects:117
Source:FDA Structured Product Label

ROPIVACAINE

Side effects:118
Source:FDA Structured Product Label

ROPIVACAINE HYDROCHLORIDE / NAROPIN INJ 10MG/ML

Side effects:127
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label